Caladrius

Caladrius is a biopharmaceutical company that develops and commercializes cell-based therapeutics for the treatment of cardiovascular disease. Read more

772 Followers on Owler
772 Followers on Owler
772 Followers on Owler
772 Followers on Owler

Caladrius

Caladrius is a biopharmaceutical company that develops and commercializes cell-based therapeutics for the treatment of cardiovascular disease. Read more

David J. Mazzo's photo - President & CEO of Caladrius

President & CEO

David J. Mazzo

CEO Approval Rating

91/100

Founded:

1980

Status:

PublicIndependent CompanyNASDAQCLBS

CALADRIUS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sangamo is a top competitor of Caladrius. Sangamo was founded in 1995, and is headquartered in Brisbane, California. Like Caladrius, Sangamo also competes in the Biotechnology field. Sangamo generates $115.4M more revenue vs. Caladrius.

Neurona is seen as one of Caladrius's top competitors. Neurona is headquartered in South San Francisco, California, and was founded in 2008. Like Caladrius, Neurona also operates in the Biotechnology field. Neurona generates 14% the revenue of Caladrius.

Lineage has been one of Caladrius's top competitors. Lineage's headquarters is in Carlsbad, California, and was founded in 1990. Like Caladrius, Lineage also works within the Biotechnology industry. Lineage generates 11% of Caladrius's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Cesca a competitor of Caladrius?

Caladrius Quarterly and Annual Revenue

Coming soon for Caladrius!

Annual Revenue

$16M

Caladrius's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 24M.

Caladrius Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Oct 2011

Source »
undisclosed
-

-

-

Jan 2011

Source »
undisclosed
-

These are all the companies that Caladrius has acquired. Caladrius has acquired 2 companies and its latest acquisition was in Oct 2011.

Caladrius Funding History

Since Caladrius was founded in 1980, it has participated in 8 rounds of funding. In total Caladrius has raised $153.7M. Caladrius' last funding round was on Feb 2021 for a total of $65.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Feb 2021
$65M
-
Private Placement
Jan 2021
$25M
-
Private Placement
May 2020
$4.3M
-
Private Placement
Apr 2020
$5M
-
Grant
Feb 2017
$12.2M

Since Caladrius was founded in 1980, it has participated in 8 rounds of funding. In total Caladrius has raised $153.7M. Caladrius' last funding round was on Feb 2021 for a total of $65.0M

Caladrius Investments

No recent investments found related to Caladrius

These are all the companies that Caladrius has invested in. Caladrius has invested 2 companies and its latest investment was in Oct 2011.

Caladrius News

January 6, 2021Benzinga

Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021

BASKING RIDGE, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Ca... See more »
December 14, 2020BioSpace

Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio UpdateProgram strategy and prioritization supports projection of available capital through 2021

Caladrius Biosciences, Inc. (Nasdaq: CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharma... See more »
December 10, 2020Benzinga

Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum

BASKING RIDGE, N.J., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Ca... See more »

Caladrius Blogs

Caladrius Press Releases

January 25, 2021GlobeNewswire

Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021

BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) ("C... See more »
January 19, 2021GlobeNewswire

Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction

Initiation of the Phase 2b FREEDOM trial represents the next step in development of CLBS16 as a poten... See more »
November 10, 2020GlobeNewswire

Caladrius Biosciences to Present at American Heart Association's Virtual Scientific Sessions 2020

BASKING RIDGE, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) ("C... See more »
October 29, 2020GlobeNewswire

Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) ("C... See more »
September 3, 2020GlobalNewswire

Caladrius Biosciences to Participate in the Advanced Therapies Congress & Expo 2020

BASKING RIDGE, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) ("... See more »
August 27, 2020accesswire

Caladrius Biosciences to Present at the LD 500 Virtual Conference on September 1, 2020 at 11:40 AM Eastern Time

Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmac... See more »
June 2, 2020GlobalNewswire

Caladrius Biosciences to Present on CLBS119 for COVID-19 Induced Lung Damage at the BioNJ COVID-19 Rapid Fire Research Showcase

BASKING RIDGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) ("C... See more »

Caladrius Videos

June 7, 2015CALADRIUS BIOSCIENCES YOUTUBE CHANNEL

"Dr Robin Smith on the NASDAQ CEO Signature Series" on YOUTUBE

June 7, 2015CALADRIUS BIOSCIENCES YOUTUBE CHANNEL

"Caladrius (formerly NeoStem) Profile by BTV" on YOUTUBE

June 7, 2015CALADRIUS BIOSCIENCES YOUTUBE CHANNEL

"CLBS10 Caladrius' Product Candidate for AMI" on YOUTUBE

October 9, 2014NEOSTEM YOUTUBE CHANNEL

"NeoStem's Investigational Targeted Cancer Immunotherapy For Late Stage Melanoma (2 minute)" on YOUTUBE

NeoStem's Investigational Targeted Cancer Immunotherapy For Late Stage Melanoma (2 minute)See how Neo... See more »
July 7, 2014CALADRIUS BIOSCIENCES YOUTUBE CHANNEL

"Dr. Robin Smith at the EY Gala 2014" on YOUTUBE

Social Media

Caladrius Headquarters

110 Allen Road 2nd Floor

Basking Ridge, New Jersey07920

908-842-0100

Driving Directions »

Trending Companies

Caladrius Summary

ABOUT

Overview

Caladrius is a biopharmaceutical company that develops and commercializes cell-based therapeutics for the treatment of cardiovascular disease. Caladrius was founded in 1980. Caladrius' headquarters is located in Basking Ridge, New Jersey, USA 07920. I...

CEO

Caladrius's President & CEO, David J. Mazzo, currently has an approval rating of 91%. Caladrius's primary competitors are Sangamo, Neurona & Lineage.

Website

caladrius.com

Frequently Asked Questions about Caladrius

  1. When was Caladrius founded?

    Caladrius was founded in 1980
  2. Who is Caladrius's CEO?

    Caladrius's CEO is David J. Mazzo
  3. How much revenue does Caladrius generate?

    Caladrius generates $16M in revenue
  4. How much funding does Caladrius have?

    Caladrius has historically raised $153.7M in funding
  1. Where is Caladrius's headquarters?

    Caladrius's headquarters is in Basking Ridge New Jersey, USA
  2. How many employees does Caladrius have?

    Caladrius has 25 employees
  3. What sector does Caladrius operate in?

    Caladrius is in Biotechnology, Pharmaceuticals
  4. Who are Caladrius's competitors?

    Caladrius's top competitors are Sangamo, Neurona, Lineage